Hofseth BioCare ASA: Publication of the Prospectus – Start of the Subscription Period for the Subsequent Offering

Core Viewpoint - Hofseth Biocare ASA ("HBC" or "the Company") has announced the completion of a private placement of new shares and is initiating a subsequent offering of up to 16,666,666 new Ordinary Shares at the same subscription price as the private placement [2][4]. Group 1: Private Placement and Subsequent Offering - The private placement was completed on 27 October 2025, and the terms for the subsequent offering were announced on 7 November 2025 [2]. - The subscription period for the subsequent offering starts on 10 November 2025 at 09:00 (CET) and ends on 20 November 2025 at 16:30 (CET) [4]. - The Company has prepared a national prospectus in accordance with the Norwegian Securities Trading Act, which has been registered and is available on the Company's website [3]. Group 2: Legal and Regulatory Information - The announcement clarifies that it does not constitute an offer to sell or a solicitation to purchase any securities of the Company [5][12]. - The securities mentioned have not been registered under the U.S. Securities Act and may not be offered or sold in the United States without registration or an applicable exemption [6]. - The communication is directed only at qualified investors in the EEA Member States and relevant persons in the United Kingdom [7][8].